Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

REGENXBIO Inc.

RGNX Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown
RGNX Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
RGNX Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
RGNX Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in RGNX holdings by institutional investors

Quarterly net insider trading by RGNX's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $60,000 Jul 20, 2026 Issue: Health Issues
  • $60,000 Jul 17, 2026 Issue: Health Issues Medical/Disease Research/Clinical Labs
  • $60,000 Jul 05, 2026 Issue: Health Issues Pharmacy
  • $60,000 Apr 20, 2026 Issue: Health Issues
  • $60,000 Apr 17, 2026 Issue: Pharmacy Health Issues
  • $60,000 Apr 16, 2026 Issue: Health Issues Medical/Disease Research/Clinical Labs
  • $40,000 Jan 16, 2026 Issue: Health Issues Medical/Disease Research/Clinical Labs
  • $60,000 Jan 12, 2026 Issue: Pharmacy Medicare/Medicaid
  • $60,000 Oct 20, 2025 Issue: Pharmacy Medicare/Medicaid
  • $91,000 Jan 22, 2024 Issue: Taxation/Internal Revenue Code Immigration Copyright/Patent/Trademark Trade (domestic/foreign) Health Issues
  • $94,000 Oct 16, 2023 Issue: Taxation/Internal Revenue Code Immigration Copyright/Patent/Trademark Trade (domestic/foreign) Health Issues
  • $90,000 Jul 19, 2023 Issue: Taxation/Internal Revenue Code Immigration Copyright/Patent/Trademark Trade (domestic/foreign) Health Issues
  • $70,000 Jan 18, 2023 Issue: Taxation/Internal Revenue Code Immigration Copyright/Patent/Trademark Trade (domestic/foreign) Health Issues
  • $70,000 Oct 15, 2022 Issue: Taxation/Internal Revenue Code Immigration Copyright/Patent/Trademark Trade (domestic/foreign) Health Issues
  • $82,000 Jul 20, 2022 Issue: Taxation/Internal Revenue Code Immigration Copyright/Patent/Trademark Trade (domestic/foreign) Health Issues
  • $150,000 Apr 20, 2022 Issue: Taxation/Internal Revenue Code Immigration Copyright/Patent/Trademark Trade (domestic/foreign) Health Issues
  • $60,000 Jan 17, 2022 Issue: None
  • $75,000 Dec 14, 2021 Issue: None
  • $40,000 Jul 20, 2021 Issue: None
  • $60,000 Apr 21, 2021 Issue: None
  • $60,000 Jan 21, 2021 Issue: None
  • $60,000 Oct 20, 2020 Issue: None
  • $185,000 Jul 20, 2020 Issue: None
  • $110,000 Apr 20, 2020 Issue: None
  • $50,000 Jan 31, 2020 Issue: None
  • $50,000 Oct 21, 2019 Issue: Immigration Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
  • $130,000 Aug 06, 2019 Issue: Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark
  • $50,000 Apr 19, 2019 Issue: Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)

Former government officials who have lobbied for RGNX

8 former government officials from 6 congressional offices at 5 lobbying firms have lobbied for RGNX, most recently Jul 05, 2026.

  • Jon C. Porter
    Alanna Temme House Legislative Director, U.S. Representative Jon Porter Formerly with Jon C. Porter · LMH STRATEGIC SOLUTIONS · Jul 05, 2026
  • Martha Roby
    Sophie Khanahmadi House Legislative Asst., Rep. Martha Roby; Legislative Asst., Rep. Lee Terry; Staff Asst./LC, Senator Jeff Sessions Formerly with Martha Roby · LMH STRATEGIC SOLUTIONS · Apr 17, 2026
  • Lamar Alexander
    David Cleary Senate New Republican Staff Director, Senate Committee on Health, Education, Labor and Pensions; Chief of Staff, Sen. Lamar Alexander; Professional Staff, House Education and Workforce Committee. Formerly with Lamar Alexander · THEGROUP DC, LLC · Feb 02, 2026
  • Alan B. Mollohan
    Maren Mcbride House New Counsel, Rep. Mollohan Formerly with Alan B. Mollohan · DLA PIPER LLP (US) · Dec 15, 2025
  • Richard Burr Senate New U.S. Senator Formerly U.S. Senator · DLA PIPER LLP (US) · Dec 15, 2025
  • Richard Burr
    Margaret Martin Senate New Senior FDA Policy Advisor, Senate Health, Education, Labor and Pensions Committee; Health Policy Assistant, Sen. Richard Burr Formerly with Richard Burr · DLA PIPER LLP (US) · Dec 15, 2025
  • Orrin G. Hatch
    Patricia Knight Senate Chief of Staff, Senator Orrin Hatch; Health Policy Director, Senator Orrin Hatch. Formerly with Orrin G. Hatch · KNIGHT CAPITOL CONSULTANTS · Jan 23, 2024
  • Bruce Artim Senate Senate Judiciary Committee Staff Member 1995-2006; (Chief Counsel and Staff Director 2003-04); Intellectual Property Subcommittee - Chief Counsel and Staff Director 2005-06) Formerly Senate Judiciary Committee Staff Member 1995-2006; (Chief Counsel and Staff Dire · REGENXBIO · Jan 22, 2024

RGNX Estimated quarterly lobbying spending

RGNX Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
RGNX Income Statement
RGNX Balance Sheet
RGNX Cash Flow
U.S. Patents

New RGNX patent grants

  • Patent Title: Microdystrophin gene therapy constructs and uses thereof Aug. 04, 2026
  • Patent Title: Scalable method for recombinant aav production Apr. 28, 2026
  • Patent Title: Methods of size exclusion chromatography for the characterization of recombinant adeno-associated virus compositions Mar. 03, 2026
  • Patent Title: Scalable clarification process for recombinant aav production Jul. 22, 2025
  • Patent Title: Anion exchange chromatography for recombinant aav production Aug. 27, 2024
  • Patent Title: Treatment of mucopolysaccharidosis ii with recombinant human iduronate-2-sulfatase (ids) May. 21, 2024
  • Patent Title: Treatment of mucopolysaccharidosis ii with recombinant human iduronate-2-sulfatase (ids) produced by human neural or glial cells Mar. 28, 2023
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to RGNX from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
RGNX News

Recent insights relating to RGNX

CNBC Recommendations

Recent picks made for RGNX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in RGNX

RGNX Analyst Ratings

RGNX Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
RGNX Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $RGNX stock a Buy, Sell, or Hold?

  • What is the price target for $RGNX stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

RGNX Top Shareholders
Shareholder
Shares Held
RGNX Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $RGNX stock?

  • Who owns the most shares of $RGNX stock?

  • What funds own $RGNX stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

RGNX Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view RGNX Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About RGNX

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

  • Address Rockville, MD
  • Market Cap 495.1 million
  • Employees 371
  • Industrial Classification Biological Products, (No Diagnostic Substances)

REGENXBIO Inc. (RGNX) Historical Stock Prices

REGENXBIO Inc. (RGNX) closed at $7.50 on September 23, 2026. Over the past year its adjusted close ranged from $5.65 to $15.98. Daily prices go back to September 17, 2015, 2,770 trading days in all.

  • 1 month-6.89%
  • 3 months-24.77%
  • Year to date-47.92%
  • 1 year-16.01%
  • 3 years-56.17%
  • 5 years-82.28%
  • Max-75.37%
See every congressional and insider trade on the RGNX price chart

Quiver Premium charts RGNX's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 8.13 8.14 7.40 7.50 7.50 1,113,282
Sep 22, 2026 8.03 8.25 7.90 8.15 8.15 1,202,480
Sep 21, 2026 8.24 8.31 7.76 7.88 7.88 1,115,691
Sep 18, 2026 8.22 8.33 8.00 8.03 8.03 3,375,140
Sep 17, 2026 8.34 8.56 8.02 8.21 8.21 1,808,112
Sep 16, 2026 7.93 7.99 7.64 7.98 7.98 1,231,601
Sep 15, 2026 8.69 8.75 7.78 7.95 7.95 1,427,119
Sep 14, 2026 8.58 8.73 8.49 8.69 8.69 858,446
Sep 11, 2026 8.69 8.82 8.39 8.53 8.53 1,029,133
Sep 10, 2026 8.63 8.79 8.47 8.56 8.56 1,172,065
Sep 9, 2026 8.70 9.03 8.62 8.73 8.73 1,407,564
Sep 8, 2026 8.95 8.95 8.60 8.76 8.76 998,959
Sep 4, 2026 9.09 9.21 8.86 8.94 8.94 1,070,570
Sep 3, 2026 9.56 9.56 9.00 9.20 9.20 839,248
Sep 2, 2026 9.34 9.71 9.20 9.60 9.60 866,267
Sep 1, 2026 9.38 9.62 9.28 9.32 9.32 783,801
Aug 31, 2026 9.50 9.68 9.09 9.50 9.50 1,612,317
Aug 28, 2026 10.00 10.10 9.21 9.66 9.66 1,754,144
Aug 27, 2026 9.35 9.46 9.04 9.37 9.37 916,585
Aug 26, 2026 8.85 9.43 8.61 9.38 9.38 1,160,019
Aug 25, 2026 8.14 8.99 8.13 8.91 8.91 1,756,781
Aug 24, 2026 8.29 8.64 7.77 8.05 8.05 5,446,547
Aug 21, 2026 11.14 11.16 10.49 10.72 10.72 1,007,024
Aug 20, 2026 11.97 12.08 11.03 11.06 11.06 947,369
Aug 19, 2026 11.50 12.04 11.50 12.02 12.02 1,146,910
Aug 18, 2026 11.13 11.20 10.73 11.07 11.07 623,930
Aug 17, 2026 10.69 11.36 10.53 11.33 11.33 1,041,992
Aug 14, 2026 10.68 10.86 10.34 10.77 10.77 792,514
Aug 13, 2026 11.03 11.25 10.61 10.66 10.66 805,581
Aug 12, 2026 10.77 11.21 10.68 10.91 10.91 877,342
Aug 11, 2026 10.56 10.79 10.15 10.65 10.65 881,200
Aug 10, 2026 10.52 10.87 10.27 10.42 10.42 988,832
Aug 7, 2026 11.05 11.39 10.31 10.72 10.72 1,387,934
Aug 6, 2026 11.28 11.50 10.85 11.28 11.28 1,769,213
Aug 5, 2026 10.32 10.79 10.20 10.50 10.50 1,521,969
Aug 4, 2026 10.13 10.43 9.87 10.30 10.30 968,718
Aug 3, 2026 9.75 10.01 9.31 9.96 9.96 812,917
Jul 31, 2026 10.25 10.38 9.63 9.69 9.69 1,157,484
Jul 30, 2026 9.75 10.14 9.53 10.12 10.12 1,215,253
Jul 29, 2026 9.65 9.90 9.46 9.62 9.62 1,089,614
Jul 28, 2026 9.59 9.77 9.18 9.60 9.60 1,389,866
Jul 27, 2026 10.05 10.51 9.65 9.71 9.71 1,248,613
Jul 24, 2026 10.24 10.34 9.57 9.73 9.73 974,331
Jul 23, 2026 9.94 10.32 9.68 10.25 10.25 1,364,649
Jul 22, 2026 10.08 10.50 10.01 10.20 10.20 1,153,447
Jul 21, 2026 10.19 10.49 9.92 10.34 10.34 1,980,710
Jul 20, 2026 10.01 10.78 10.01 10.32 10.32 2,280,553
Jul 17, 2026 8.99 10.24 8.42 9.89 9.89 7,516,947
Jul 16, 2026 12.15 12.15 11.02 11.20 11.20 2,007,778
Jul 15, 2026 12.16 12.36 11.83 12.27 12.27 1,197,214
Jul 14, 2026 13.00 13.00 12.18 12.29 12.29 1,574,285
Jul 13, 2026 13.56 13.56 12.19 12.75 12.75 2,184,741
Jul 10, 2026 15.57 15.65 13.42 13.95 13.95 3,350,906
Jul 9, 2026 15.37 15.75 14.92 15.65 15.65 1,975,543
Jul 8, 2026 14.99 15.88 14.87 15.23 15.23 2,388,233
Jul 7, 2026 14.94 15.71 14.10 15.02 15.02 2,757,114
Jul 6, 2026 13.54 15.30 13.53 14.83 14.83 3,152,695
Jul 2, 2026 13.62 14.25 13.16 13.28 13.28 3,298,799
Jul 1, 2026 11.89 13.68 11.89 13.09 13.09 4,537,736
Jun 30, 2026 11.85 12.26 11.63 11.98 11.98 1,617,577
Jun 29, 2026 11.12 11.86 10.86 11.83 11.83 2,544,163
Jun 26, 2026 10.22 10.78 9.94 10.48 10.48 4,356,521
Jun 25, 2026 10.07 10.93 9.97 10.24 10.24 1,550,500
Jun 24, 2026 10.13 10.98 9.86 9.97 9.97 2,384,295
Jun 23, 2026 8.94 10.34 8.94 9.95 9.95 2,968,623
Jun 22, 2026 8.52 9.65 7.81 9.07 9.07 9,094,401
Jun 18, 2026 8.20 8.57 7.78 7.80 7.80 3,205,429
Jun 17, 2026 7.18 8.73 7.18 7.90 7.90 4,964,676
Jun 16, 2026 7.07 7.13 6.58 6.93 6.93 967,544
Jun 15, 2026 6.79 7.11 6.75 7.07 7.07 1,642,812
Jun 12, 2026 6.36 6.67 6.32 6.66 6.66 904,546
Jun 11, 2026 6.07 6.32 5.88 6.28 6.28 1,393,827
Jun 10, 2026 6.33 6.51 6.09 6.13 6.13 821,869
Jun 9, 2026 6.23 6.47 6.07 6.34 6.34 1,986,963
Jun 8, 2026 6.11 6.30 5.95 6.13 6.13 1,198,045
Jun 5, 2026 6.83 6.91 6.00 6.08 6.08 1,699,331
Jun 4, 2026 6.77 7.18 6.70 6.88 6.88 1,253,385
Jun 3, 2026 6.73 6.78 6.52 6.69 6.69 1,284,829
Jun 2, 2026 7.07 7.09 6.44 6.52 6.52 1,501,799
Jun 1, 2026 6.93 7.32 6.86 7.14 7.14 1,160,678
May 29, 2026 7.04 7.09 6.82 7.01 7.01 1,127,892
May 28, 2026 6.63 6.98 6.62 6.89 6.89 1,519,112
May 27, 2026 6.35 6.75 6.35 6.69 6.69 1,534,554
May 26, 2026 6.31 6.38 6.08 6.31 6.31 1,421,432
May 22, 2026 6.73 6.88 6.30 6.35 6.35 1,569,528
May 21, 2026 5.89 6.79 5.79 6.75 6.75 2,972,661
May 20, 2026 5.63 6.04 5.57 5.97 5.97 2,246,605
May 19, 2026 5.70 5.72 5.50 5.66 5.66 1,784,662
May 18, 2026 5.72 5.83 5.46 5.65 5.65 2,610,540
May 15, 2026 6.25 6.48 5.71 5.72 5.72 4,346,839
May 14, 2026 8.08 8.13 6.01 6.25 6.25 10,322,862
May 13, 2026 10.07 10.25 9.65 10.04 10.04 1,809,156
May 12, 2026 9.96 10.36 9.92 10.24 10.24 1,024,441
May 11, 2026 10.71 11.36 9.96 10.08 10.08 1,581,494
May 8, 2026 10.63 10.86 10.20 10.55 10.55 1,379,404
May 7, 2026 10.11 10.44 9.87 10.42 10.42 1,468,940
May 6, 2026 9.35 10.40 9.29 10.22 10.22 1,456,340
May 5, 2026 9.50 9.64 8.96 9.22 9.22 436,646
May 4, 2026 9.01 9.46 8.94 9.39 9.39 678,089
May 1, 2026 8.97 9.50 8.95 9.12 9.12 566,271
Apr 30, 2026 8.78 9.02 8.55 8.97 8.97 525,478
Apr 29, 2026 8.68 8.68 8.15 8.40 8.40 654,052
Apr 28, 2026 8.65 8.84 8.60 8.69 8.69 542,501
Apr 27, 2026 8.76 9.15 8.44 8.62 8.62 674,688
Apr 24, 2026 8.89 9.04 8.59 8.76 8.76 757,033
Apr 23, 2026 9.33 9.55 8.89 8.99 8.99 483,731
Apr 22, 2026 9.28 9.52 9.24 9.34 9.34 401,531
Apr 21, 2026 9.50 9.59 9.03 9.11 9.11 638,744
Apr 20, 2026 9.30 9.67 9.10 9.47 9.47 656,227
Apr 17, 2026 9.48 9.62 9.28 9.49 9.49 454,375
Apr 16, 2026 9.36 9.42 9.04 9.19 9.19 365,729
Apr 15, 2026 9.29 9.60 9.26 9.36 9.36 651,848
Apr 14, 2026 9.09 9.42 9.09 9.30 9.30 577,728
Apr 13, 2026 8.79 9.15 8.71 9.04 9.04 805,982
Apr 10, 2026 9.03 9.11 8.64 8.80 8.80 480,514
Apr 9, 2026 8.54 9.00 8.41 8.96 8.96 470,975
Apr 8, 2026 9.21 9.33 8.53 8.67 8.67 587,385
Apr 7, 2026 8.76 8.94 8.49 8.80 8.80 494,244
Apr 6, 2026 8.53 9.07 8.51 8.80 8.80 560,351
Apr 2, 2026 8.31 8.68 8.10 8.53 8.53 420,975
Apr 1, 2026 8.61 8.89 8.42 8.63 8.63 526,748
Mar 31, 2026 8.05 8.53 8.04 8.38 8.38 566,686
Mar 30, 2026 7.75 7.88 7.58 7.77 7.77 619,998
Mar 27, 2026 8.18 8.35 7.71 7.76 7.76 630,949
Mar 26, 2026 8.25 8.78 8.21 8.26 8.26 586,837
Mar 25, 2026 8.04 8.47 8.04 8.46 8.46 930,900
Mar 24, 2026 8.13 8.23 7.74 7.81 7.81 711,992
Mar 23, 2026 8.34 8.71 8.24 8.34 8.34 791,864
Mar 20, 2026 8.33 8.48 8.06 8.10 8.10 2,687,263
Mar 19, 2026 8.18 8.46 8.02 8.36 8.36 739,531
Mar 18, 2026 8.59 8.62 8.15 8.28 8.28 641,187
Mar 17, 2026 8.80 8.94 8.61 8.64 8.64 635,019
Mar 16, 2026 8.70 9.00 8.66 8.79 8.79 554,174
Mar 13, 2026 9.08 9.10 8.25 8.57 8.57 1,058,135
Mar 12, 2026 9.31 9.31 8.92 9.08 9.08 710,299
Mar 11, 2026 9.76 9.80 9.15 9.38 9.38 726,912
Mar 10, 2026 10.35 10.77 9.87 9.90 9.90 1,112,616
Mar 9, 2026 9.75 10.76 9.72 10.38 10.38 1,931,396
Mar 6, 2026 8.46 8.69 8.30 8.65 8.65 1,383,917
Mar 5, 2026 8.41 8.75 8.01 8.72 8.72 1,470,655
Mar 4, 2026 8.73 9.34 8.53 9.14 9.14 878,388
Mar 3, 2026 9.35 9.35 8.59 8.69 8.69 754,300
Mar 2, 2026 8.71 9.65 8.53 9.24 9.24 1,454,423
Feb 27, 2026 8.62 9.22 8.55 9.04 9.04 811,920
Feb 26, 2026 8.55 8.76 8.24 8.75 8.75 917,175
Feb 25, 2026 8.08 8.82 8.08 8.53 8.53 689,528
Feb 24, 2026 7.85 8.29 7.85 8.08 8.08 575,716
Feb 23, 2026 8.29 8.42 7.80 7.94 7.94 662,946
Feb 20, 2026 8.30 8.83 8.04 8.14 8.14 1,019,525
Feb 19, 2026 7.86 8.45 7.61 8.41 8.41 849,230
Feb 18, 2026 8.00 8.22 7.83 7.90 7.90 531,484
Feb 17, 2026 7.93 8.13 7.74 8.04 8.04 783,860
Feb 13, 2026 8.35 8.63 7.94 7.99 7.99 1,095,033
Feb 12, 2026 8.49 8.54 8.12 8.35 8.35 964,326
Feb 11, 2026 8.81 8.98 8.21 8.50 8.50 1,088,164
Feb 10, 2026 9.02 9.31 8.40 8.85 8.85 2,509,976
Feb 9, 2026 10.14 10.62 10.01 10.31 10.31 955,423
Feb 6, 2026 10.73 10.95 10.32 10.33 10.33 1,004,905
Feb 5, 2026 10.50 11.20 10.15 10.26 10.26 961,321
Feb 4, 2026 10.71 10.86 10.51 10.75 10.75 759,785
Feb 3, 2026 10.65 11.26 10.61 10.86 10.86 701,880
Feb 2, 2026 10.90 11.32 10.45 10.78 10.78 817,755
Jan 30, 2026 11.23 11.56 10.97 11.16 11.16 1,010,011
Jan 29, 2026 10.81 11.78 10.60 11.60 11.60 1,611,567
Jan 28, 2026 9.61 11.50 9.51 11.01 11.01 5,016,735
Jan 27, 2026 13.91 14.17 13.26 13.41 13.41 697,946
Jan 26, 2026 14.00 14.20 13.35 13.86 13.86 877,982
Jan 23, 2026 15.90 16.00 13.75 13.79 13.79 1,411,508
Jan 22, 2026 15.10 16.19 15.00 15.98 15.98 810,486
Jan 21, 2026 14.29 15.19 14.22 15.02 15.02 889,418
Jan 20, 2026 13.53 14.61 13.40 14.10 14.10 902,703
Jan 16, 2026 13.89 14.22 13.56 13.62 13.62 650,747
Jan 15, 2026 15.02 15.02 13.68 13.76 13.76 1,098,578
Jan 14, 2026 15.05 15.31 14.74 14.95 14.95 531,309
Jan 13, 2026 14.99 15.12 14.53 15.05 15.05 527,731
Jan 12, 2026 15.47 15.84 14.85 15.08 15.08 1,009,435
Jan 9, 2026 15.13 15.62 14.55 14.59 14.59 450,923
Jan 8, 2026 15.02 15.17 14.59 15.00 15.00 654,128
Jan 7, 2026 14.44 15.80 14.38 15.24 15.24 867,292
Jan 6, 2026 13.72 14.40 13.55 14.18 14.18 569,227
Jan 5, 2026 13.61 13.76 12.87 13.40 13.40 510,240
Jan 2, 2026 14.65 14.65 12.91 13.57 13.57 1,326,974
Dec 31, 2025 13.98 14.48 13.94 14.40 14.40 667,284
Dec 30, 2025 14.23 14.44 13.66 14.09 14.09 1,483,764
Dec 29, 2025 14.06 14.36 13.87 14.30 14.30 862,650
Dec 26, 2025 14.39 14.42 13.89 14.16 14.16 276,508
Dec 24, 2025 14.40 14.72 14.26 14.46 14.46 191,155
Dec 23, 2025 14.81 14.94 14.28 14.35 14.35 467,466
Dec 22, 2025 14.74 15.41 14.61 14.97 14.97 598,000
Dec 19, 2025 13.79 15.20 13.51 14.59 14.59 1,097,051
Dec 18, 2025 13.52 14.16 13.20 13.51 13.51 662,769
Dec 17, 2025 14.07 14.45 12.91 13.17 13.17 541,970
Dec 16, 2025 13.72 14.34 13.68 14.11 14.11 677,674
Dec 15, 2025 14.37 14.93 13.74 13.83 13.83 1,384,957
Dec 12, 2025 12.90 14.24 12.69 13.87 13.87 604,477
Dec 11, 2025 13.06 13.41 12.76 12.85 12.85 593,150
Dec 10, 2025 12.65 13.42 12.61 13.06 13.06 701,985
Dec 9, 2025 13.21 13.34 12.65 12.72 12.72 543,870
Dec 8, 2025 13.44 13.99 13.08 13.24 13.24 492,331
Dec 5, 2025 13.06 13.29 12.87 13.16 13.16 555,168
Dec 4, 2025 12.88 13.77 12.82 12.98 12.98 941,068
Dec 3, 2025 12.22 12.93 12.21 12.88 12.88 457,525
Dec 2, 2025 12.70 12.90 12.05 12.21 12.21 543,296
Dec 1, 2025 13.00 13.24 12.42 12.60 12.60 523,742
Nov 28, 2025 13.25 13.39 13.01 13.39 13.39 1,097,378
Nov 26, 2025 13.53 13.80 13.11 13.26 13.26 906,733
Nov 25, 2025 12.23 13.65 12.04 13.45 13.45 967,355
Nov 24, 2025 11.87 12.50 11.81 12.23 12.23 723,993
Nov 21, 2025 10.87 11.97 10.76 11.80 11.80 453,196
Nov 20, 2025 11.18 11.58 10.83 10.87 10.87 445,167
Nov 19, 2025 11.04 11.30 10.82 10.93 10.93 585,786
Nov 18, 2025 11.01 11.49 10.70 11.25 11.25 528,279
Nov 17, 2025 11.45 11.77 10.95 11.14 11.14 540,800
Nov 14, 2025 11.29 11.91 11.25 11.51 11.51 512,057
Nov 13, 2025 11.41 12.05 11.31 11.64 11.64 561,026
Nov 12, 2025 11.55 12.01 11.42 11.60 11.60 515,556
Nov 11, 2025 10.99 11.61 10.90 11.55 11.55 474,733
Nov 10, 2025 11.65 11.81 10.86 11.02 11.02 542,699
Nov 7, 2025 11.00 11.34 10.80 11.21 11.21 623,204
Nov 6, 2025 11.40 11.79 11.00 11.17 11.17 677,348
Nov 5, 2025 11.46 11.85 11.26 11.61 11.61 481,136
Nov 4, 2025 11.42 11.96 11.38 11.56 11.56 550,111
Nov 3, 2025 12.40 12.45 11.47 11.99 11.99 903,058
Oct 31, 2025 12.82 13.20 12.61 12.77 12.77 473,911
Oct 30, 2025 12.75 13.26 12.75 12.82 12.82 331,616
Oct 29, 2025 13.10 13.40 12.65 12.84 12.84 554,964
Oct 28, 2025 13.58 13.69 13.12 13.16 13.16 507,034
Oct 27, 2025 13.44 13.93 13.13 13.62 13.62 497,441
Oct 24, 2025 12.80 13.28 12.72 13.03 13.03 461,869
Oct 23, 2025 12.20 12.63 12.06 12.58 12.58 450,053
Oct 22, 2025 12.99 12.99 12.17 12.19 12.19 658,523
Oct 21, 2025 12.56 13.39 12.19 13.09 13.09 681,779
Oct 20, 2025 12.06 12.82 12.02 12.64 12.64 618,345
Oct 17, 2025 11.52 12.31 11.50 11.73 11.73 392,966
Oct 16, 2025 12.43 12.99 12.27 12.34 12.34 742,307
Oct 15, 2025 11.34 12.35 11.34 12.30 12.30 569,697
Oct 14, 2025 10.90 11.40 10.90 11.25 11.25 403,076
Oct 13, 2025 11.33 11.60 10.97 11.34 11.34 506,787
Oct 10, 2025 12.11 12.14 10.91 10.92 10.92 968,746
Oct 9, 2025 12.28 12.84 12.15 12.17 12.17 1,023,565
Oct 8, 2025 10.53 12.30 10.52 12.22 12.22 973,125
Oct 7, 2025 10.73 11.00 10.24 10.51 10.51 513,537
Oct 6, 2025 10.53 10.85 10.48 10.69 10.69 699,148
Oct 3, 2025 10.58 11.00 10.42 10.43 10.43 692,205
Oct 2, 2025 9.81 10.58 9.81 10.58 10.58 671,850
Oct 1, 2025 9.57 9.98 9.55 9.77 9.77 612,354
Sep 30, 2025 9.83 10.01 9.63 9.65 9.65 906,890
Sep 29, 2025 9.74 10.17 9.68 9.85 9.85 706,821
Sep 26, 2025 9.37 9.67 9.18 9.65 9.65 488,956
Sep 25, 2025 9.41 9.73 9.18 9.36 9.36 560,971
Sep 24, 2025 9.05 9.58 8.97 9.54 9.54 579,212
Sep 23, 2025 9.05 9.12 8.80 8.93 8.93 407,546

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
REGENXBIO Inc. Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at RGNX, per a recent SEC DEF 14A filing. We estimate that the median employee at REGENXBIO Inc. is paid $226,641.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation